FEMAMED 2.5 Letrozole
Known names: Femara, Letroz, Trozet, Oncolet.
PRODUCT DESCRIPTION:
FEMAMED 2.5 (Letrozole) is an essential member of the aromatase inhibitor family, renowned for its effectiveness in treating hormonal or endocrine breast cancer. The growth of breast cancer cells is often propelled by the presence of estrogens, which are predominantly found in female sex hormones.
Through its mechanism of action, FEMAMED 2.5 actively diminishes estrogen levels by inhibiting the aromatase enzyme responsible for estrogen production. By significantly reducing estrogen production, it effectively impedes the growth of estrogen-dependent breast cancer cells, which rely on estrogen to thrive.
As a crucial component of breast cancer treatment, FEMAMED 2.5 holds significant potential in combating the progression of the disease and promoting positive patient outcomes.
PACKAGE CONTENT:
1 Box of 2×25 Tablets, 2.5mg per Tablet.
SPECIAL STORAGE INSTRUCTIONS:
Keep the product stored below 30°C.
Protect it from light exposure and avoid freezing.
Reviews
There are no reviews yet.